CDT Equity Inc. Implements 1-for-25 Reverse Stock Split to Boost Share Price
CDT is trading near its 52-week low of $0.442 (0.5% below the low) on light trading volume (0.1× avg).
Summary
CDT Equity Inc. will implement a 1-for-25 reverse stock split effective March 26, 2026, to increase its share price, likely to maintain its Nasdaq listing.
Key Events · Corporate Governance and Compliance · CDT
-
Reverse Stock Split Details
CDT Equity Inc. filed a certificate of amendment to effectuate a 1-for-25 reverse stock split of its common stock, effective March 26, 2026, at 5:00 p.m. Eastern Time.
-
Nasdaq Trading Adjustment
The common stock is expected to begin trading on The Nasdaq Capital Market on a reverse stock split-adjusted basis on March 27, 2026, under the existing ticker symbol 'CDT'.
-
Fractional Shares Handled by Cash Payment
No fractional shares will be issued; stockholders entitled to a fractional share will receive a cash payment based on the closing price on March 26, 2026.
-
Share Count Reduction
After the reverse stock split, the number of outstanding shares of common stock will be reduced to approximately 4,722,450.
Analysis · CDT · Life Sciences
CDT Equity Inc. is executing a significant 1-for-25 reverse stock split, a common maneuver for companies whose stock price has fallen below exchange minimums, likely to maintain its Nasdaq listing. While it increases the per-share price, it does not change the company's overall market capitalization or fundamental value. Investors should be aware that reverse splits often precede further price declines if the underlying business issues are not resolved. The company's stock is currently trading near its 52-week low, underscoring the urgency of this action. The reduction in outstanding shares could lead to increased volatility.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 35.6% of the 1805 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CDT was trading at $0.44 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.2M. The 52-week trading range was $0.44 to $168.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.